Andrew P McGovern

17PUBLICATIONS
31CO-AUTHORS
Gene and molecular therapyNutrigenomics and personalised nutritionMolecular targetsMajor global burdens of diseasePreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 20, 2026
Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study.

|Nov 09, 2025
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection.

Thijs T Jansz, Katherine G Young, Rhian Hopkins

|Jun 05, 2024
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach.

Laura M Güdemann, Katie G Young, Nicholas J M Thomas

|Jan 31, 2024
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study.

Rhian Hopkins, Katherine G Young, Nicholas J Thomas

|Jun 05, 2023
HbA

Katherine G Young, Andrew P McGovern, Inês Barroso

|May 22, 2023
Correction to: The impact of population-level HbA<sub>1c</sub> screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis.

Katherine G Young, Andrew P McGovern, Inês Barroso

Pageof 3

Frequent Collaborators

8 joint publications

Raphael Sonabend

8 joint publications

Beverley M Shields

7 joint publications

Andrew T Hattersley

6 joint publications

Angus G Jones